Lynn Devilée
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- Pluripotent Stem Cells Research
- Protein Degradation and Inhibitors
- Congenital heart defects research
Papers in
-
- Pluripotent Stem Cells Research 3
- Congenital heart defects research 2
- Protein Degradation and Inhibitors 1
-
- COVID-19 Clinical Research Studies 1
- SARS-CoV-2 and COVID-19 Research 1
- Co-authors
- Michele Gabriele (1 shared paper)Anouk H. A. Verboven (1 shared paper)Teun M. Klein Gunnewiek (1 shared paper)Chantal Schoenmaker (1 shared paper)de Vries Bj (1 shared paper)Astrid R. Oudakker (1 shared paper)Monica Frega (1 shared paper)David A. Koolen (1 shared paper)
- Journals
- npj Regenerative Medicine (1 paper)Autophagy (1 paper)Cell Reports (1 paper)Cell (1 paper)bioRxiv (Cold Spring Harbor Laboratory) (1 paper)
- Partner nations
- AustraliaUnited StatesSaudi Arabia
In The Last Decade
Lynn Devilée
5 papers receiving 337 citations
Peers
Comparison fields: 5 of 45
- Infectious Diseases 53
- Molecular Biology 159
- Cardiology and Cardiovascular Medicine 47
- Biomedical Engineering 68
- Neurology 15
Countries citing papers authored by Lynn Devilée
This map shows the geographic impact of Lynn Devilée's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Devilée with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Devilée more than expected).
Fields of papers citing papers by Lynn Devilée
This network shows the impact of papers produced by Lynn Devilée. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Devilée. The network helps show where Lynn Devilée may publish in the future.
Co-authors
The 25 scholars most cited alongside Lynn Devilée, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 176 | |
| 2 | 2023 | 94 | |
| 3 | 2021 | 55 | |
| 4 | 2025 | 13 | |
| 5 | 2025 | 8 | |
| 6 | 2025 | 0 | |
| 7 | 2026 | 0 |
About Lynn Devilée
Lynn Devilée is a scholar working on Molecular Biology, Infectious Diseases, Epidemiology, Surgery and Nuclear Energy and Engineering, having authored 7 papers that have together received 346 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (3 papers), Congenital heart defects research (2 papers), Autophagy in Disease and Therapy (1 paper), COVID-19 Clinical Research Studies (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Protein Degradation and Inhibitors (1 paper) and Tissue Engineering and Regenerative Medicine (1 paper). The work is most often cited by research in Infectious Diseases (53 citations), Molecular Biology (159 citations), Cardiology and Cardiovascular Medicine (47 citations), Biomedical Engineering (68 citations) and Neurology (15 citations). Lynn Devilée has collaborated with scholars based in Australia, United States and Saudi Arabia. Frequent co-authors include Michele Gabriele, Anouk H. A. Verboven, Teun M. Klein Gunnewiek, Chantal Schoenmaker, de Vries Bj, Astrid R. Oudakker, Monica Frega, David A. Koolen, Giuseppe Testa and Hans van Bokhoven. Their work appears in journals such as npj Regenerative Medicine, Autophagy, Cell Reports, Cell and bioRxiv (Cold Spring Harbor Laboratory).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.